Belluscura Plc engages in the provision of medical devices. The firm focuses on developing oxygen enrichment technology spanning broad industries and therapies. Its oxygen technologies are designed with a global purpose to create improved health and economic outcomes for the patients, healthcare providers and insurance organizations. The company was founded on December 10, 2015 and is headquartered in London, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company